This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Serth, J. Articles by Jonas, U. Search for Related Content PubMed PubMed Citation Articles by Serth, J. Articles by Jonas, U.

Increased Levels of Human Papillomavirus Type 16 DNA in a Subset of Prostate Cancers¹

Department of Urology, Hannover Medical School, D-30625 Hannover, Germany

Whether oncogenic human papilloma viruses (HPVs) are involved in the pathogenesis of prostate cancers has been a subject of great controversy. To clarify the contradictory results of investigations, with the aim of detecting viral nucleic acids in prostate cancers, we have carried out a comparative quantitation of the HPV16-E6 sequence in 84 prostate specimens. Using single-tube quantitative competitive PCR, we characterized 47 prostate cancers and 37 control tissues of benign prostatic hyperplasia. A subgroup of the prostate tumors (10 of 47; 21%) was detected as having significantly higher copy numbers of HPV16-E6 sequences when compared to the control tissue (1 of 37; 3%), using a cutoff value of 300 copies per 12,500 diploid cells (two-sided Fisher’s exact test, P = 0.02). Our results indicate that the oncogenic HPV16 might contribute to the development of a subset of prostate tumors.

This article has been cited by other articles:

				W.-Y. Huang, R. Hayes, R. Pfeiffer, R. P. Viscidi, F. K. Lee, Y. F. Wang, D. Reding, D. Whitby, J. R. Papp, and C. S. Rabkin Sexually Transmissible Infections and Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2374 - 2381. [Abstract] [Full Text] [PDF]

				Z. Korodi, J. Dillner, E. Jellum, S. Lumme, G. Hallmans, S. Thoresen, T. Hakulinen, P. Stattin, T. Luostarinen, M. Lehtinen, et al. Human Papillomavirus 16, 18, and 33 Infections and Risk of Prostate Cancer: A Nordic Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2952 - 2955. [Abstract] [Full Text] [PDF]

				G. S. Palapattu, S. Sutcliffe, P. J. Bastian, E. A. Platz, A. M. De Marzo, W. B. Isaacs, and W. G. Nelson Prostate carcinogenesis and inflammation: emerging insights Carcinogenesis, July 1, 2005; 26(7): 1170 - 1181. [Abstract] [Full Text] [PDF]

				H.-O. Adami, H. Kuper, S.-O. Andersson, R. Bergstrom, and J. Dillner Prostate Cancer Risk and Serologic Evidence of Human Papilloma Virus Infection: A Population-based Case-Control Study Cancer Epidemiol. Biomarkers Prev., September 1, 2003; 12(9): 872 - 875. [Abstract] [Full Text] [PDF]

				M. L. Gillison and K. V. Shah Chapter 9: Role of Mucosal Human Papillomavirus in Nongenital Cancers J Natl Cancer Inst Monographs, June 1, 2003; 2003(31): 57 - 65. [Abstract] [Full Text] [PDF]

				Y. Yasunaga, K. Nakamura, C. M. Ewing, W. B. Isaacs, B. Hukku, and J. S. Rhim A Novel Human Cell Culture Model for the Study of Familial Prostate Cancer Cancer Res., August 1, 2001; 61(16): 5969 - 5973. [Abstract] [Full Text] [PDF]

				N. Dejucq and B. Jegou Viruses in the Mammalian Male Genital Tract and Their Effects on the Reproductive System Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 208 - 231. [Abstract] [Full Text] [PDF]

				J. Serth, M. A. Kuczyk, U. Paeslack, R. Lichtinghagen, and U. Jonas Quantitation of DNA Extracted after Micropreparation of Cells from Frozen and Formalin-Fixed Tissue Sections Am. J. Pathol., April 1, 2000; 156(4): 1189 - 1196. [Abstract] [Full Text] [PDF]

				M. Hisada, C. S. Rabkin, H. D. Strickler, W. E. Wright, R. E. Christianson, and B. J. van den Berg Human Papillomavirus Antibody and Risk of Prostate Cancer JAMA, January 19, 2000; 283(3): 340 - 341. [Full Text] [PDF]